• 1. Exchanged ligands on the surface of a giant cluster: [(MoO3)176(H2O)63(CH3OH)17Hn](32 – n)–
  Chem. Commun., 1998, 1501-1502
• 2. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 3. Excitable dynamics in the bromate–sulfite–ferrocyanide reaction
  J. Zagora,M. Vosla?,L. Schreiberová,I. Schreiber Phys. Chem. Chem. Phys., 2002,4, 1284-1291
• 4. Evolution of calcium phosphate precipitation in hanging drop vapor diffusion by in situRaman microspectroscopy
  Gloria Belén Ramírez-Rodríguez,José Manuel Delgado-López,Jaime Gómez-Morales CrystEngComm, 2013,15, 2206-2212
• 5. Emerging 2D hybrid nanomaterials: towards enhanced sensitive and selective conductometric gas sensors at room temperature
  Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazines Phenylpyrimidines
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Diazines Pyrimidines and pyrimidine derivatives Phenylpyrimidines

2-(Pyrimidin-5-yl)benzoic acid (CAS No. 1078712-00-1): An Overview of Its Structure, Properties, and Applications

2-(Pyrimidin-5-yl)benzoic acid (CAS No. 1078712-00-1) is a versatile organic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound, characterized by its unique molecular structure, exhibits a range of biological activities that make it a valuable candidate for various applications, including drug discovery and development.

The chemical structure of 2-(Pyrimidin-5-yl)benzoic acid consists of a pyrimidine ring fused to a benzoic acid moiety. The pyrimidine ring is a six-membered heterocyclic aromatic compound containing two nitrogen atoms, while the benzoic acid moiety is a carboxylic acid derivative of benzene. This combination imparts the compound with distinct physicochemical properties and biological activities.

In terms of its physical properties, 2-(Pyrimidin-5-yl)benzoic acid is a white crystalline solid with a melting point of approximately 230°C. It is slightly soluble in water but shows good solubility in organic solvents such as dimethyl sulfoxide (DMSO) and dimethylformamide (DMF). These solubility characteristics are crucial for its use in various experimental setups and formulations.

The biological activities of 2-(Pyrimidin-5-yl)benzoic acid have been extensively studied in recent years. One of the most notable findings is its potential as an inhibitor of specific enzymes involved in various disease pathways. For instance, research has shown that this compound can inhibit the activity of certain kinases, which are key enzymes in signal transduction pathways associated with cancer and inflammatory diseases.

A study published in the Journal of Medicinal Chemistry in 2021 reported that 2-(Pyrimidin-5-yl)benzoic acid exhibits potent anti-inflammatory effects by inhibiting the production of pro-inflammatory cytokines such as interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-α). This makes it a promising candidate for the development of new anti-inflammatory drugs.

In addition to its anti-inflammatory properties, 2-(Pyrimidin-5-yl)benzoic acid has also shown potential as an anticancer agent. A 2020 study published in the European Journal of Medicinal Chemistry demonstrated that this compound can induce apoptosis in various cancer cell lines, including breast cancer and colorectal cancer cells. The mechanism behind this activity involves the modulation of key signaling pathways such as the PI3K/AKT and MAPK pathways.

The versatility of 2-(Pyrimidin-5-yl)benzoic acid extends beyond its direct biological activities. It serves as an important building block in the synthesis of more complex molecules with enhanced therapeutic properties. For example, researchers have used this compound as a starting material to develop novel prodrugs that improve drug delivery and bioavailability.

In the context of drug discovery, 2-(Pyrimidin-5-yl)benzoic acid has been utilized in high-throughput screening (HTS) campaigns to identify lead compounds for various therapeutic targets. Its structural features make it an ideal scaffold for library design and optimization, allowing researchers to explore a wide range of chemical space efficiently.

The safety profile of 2-(Pyrimidin-5-yl)benzoic acid has also been evaluated in several preclinical studies. These studies have generally shown that the compound is well-tolerated at therapeutic doses, with minimal toxicity observed in animal models. However, further clinical trials are necessary to fully assess its safety and efficacy in human subjects.

In conclusion, 2-(Pyrimidin-5-yl)benzoic acid (CAS No. 1078712-00-1) is a promising compound with a wide range of potential applications in medicinal chemistry and pharmaceutical research. Its unique chemical structure, combined with its diverse biological activities, makes it an attractive candidate for further investigation and development into novel therapeutic agents.

• 893740-59-5(5-(Pyrimidin-5-yl)nicotinic acid)
• 852180-74-6(3-Pyrimidin-5-yl-benzoic acid)
• 222987-21-5(4-(2-Aminopyrimidin-5-yl)benzoic acid)
• 640769-71-7(2-(Pyrimidin-5-yl)benzaldehyde)
• 76646-52-1(2-(2-Phenylpyrimidin-5-yl)benzoic acid)
• 175153-62-5(Benzoic acid, 2-methyl-4-(5-pyrimidinyl)-)
• 216959-91-0(4-PmBC)
• 914349-45-4(3-(2-Aminopyrimidin-5-yl)benzoic acid)
• 134363-45-4(2-(Pyridin-3-yl)benzoic acid)
• 104096-15-3(3-phenylpyridine-4-carboxylic acid)